Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: Systematic review and meta-analysis

Thrombosis and Haemostasis

Volumn 117, Issue 5, 2017, Pages 889-898

  Desborough, Michael J R ^a,b   Colman, Katherine S ^c   Prick, Babette W ^d   Duvekot, Johannes J ^d   Sweeney, Connor ^e   Odutayo, Ayodele ^b   Jairath, Vipul ^f,g   Doree, Carolyn ^a   Trivella, Marialena ^b   Hopewell, Sally ^b   Estcourt, Lise J ^a,b   Stanworth, Simon J ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Haemorrhage; Myocardial infarction; Stroke; Transfusion; Venous Thromboembolism

Indexed keywords

ANEMIA; ARTERIAL THROMBOEMBOLISM; BRAIN ISCHEMIA; CLINICAL OUTCOME; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; AGED; BLEEDING; BLOOD; CHI SQUARE DISTRIBUTION; FEMALE; INFANT; MALE; METABOLISM; MIDDLE AGED; NEWBORN; ODDS RATIO; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME; VERY ELDERLY;

BIOLOGICAL MARKER; HEMOGLOBIN;

AGED; AGED, 80 AND OVER; ANEMIA; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HEMORRHAGE; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 85019650329     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH17-01-0015     Document Type: Review

References (43)

1. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980; 207: 541-543.
2. Chen H, Angerer JI, Napoleone M, et al. Hematocrit and flow rate regulate the adhesion of platelets to von Willebrand factor. Biomicrofluidics 2013; 7: 64113.
3. Walton BL, Byrnes JR, Wolberg AS. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost 2015; 13: S208-S215.
4. Whelihan MF, Zachary V, Orfeo T, et al. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 2012; 120: 3837-3845.
5. Wohner N, Sótonyi P, Machovich R, et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31: 2306-2613.
6. Horne MK 3rd, Cullinane AM, Merryman PK, et al. The effect of red blood cells on thrombin generation. Br J Haematol 2006; 133: 403-408.
7. Ho CH. Increase of red blood cells can shorten the bleeding time in patients with iron deficiency anemia. Blood 1998; 91: 1094.
8. Valeri CR, Khuri S, Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasmaclotting proteins. Transfusion 2007; 47: 206S-248S.
9. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; (41): 977-983.
10. Braekkan SK, Mathiesen EB, Njølstad I, et al. Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica 2010; 95: 270-275.
11. Silvain J, Abtan J, Kerneis M, et al. Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry). J Am Coll Cardiol 2014; 63: 1289-1296.
12. Silvain J, Pena A, Cayla G, et al. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010; 31: 2816-2821.
13. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011; 60: 1327-1335.
14. Mehta RH, Sheng S, O’Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009; 2: 583-590.
15. Dubovoy T, Engoren M. Thrombotic Risks in Red Blood Cell Transfusions. Semin Thromb Hemost 2016; 42: 102-111.
16. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
17. Holst LB, Petersen MW, Haase N, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. Br Med J 2015; 350: h1354.
18. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016; 10: CD002042.
19. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011): The Cochrane Collaboration, 2011.
20. Schünemann HJ, Oxman AD, Vist GE, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011): The Cochrane Collaboration, 2011.
21. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-971.e1.
22. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in highrisk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
23. de Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015; 122: 29-38.
24. Fan YX, Liu FF, Jia M, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Arch Gerontol Geriatr 2014; 59: 181-185.
25. Foss NB, Kristensen MT, Jensen PS, et al. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009; 49: 227-234.
26. Grover M, Talwalkar S, Casbard A, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90: 105-112.
27. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
28. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391.
29. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386: 137-144.
30. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007; 356: 1609-1619.
31. Lee JM, Chun HJ, Lee JS. Target level hemoglobin correction in patients with acute non-variceal upper gastrointestinal bleeding. Gastroenterology. 2014; 146: Abstract S-321.
32. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008.
33. Nielsen K, Johansson PI, Dahl B, et al. Perioperative transfusion threshold and ambulation after hip revision surgery--a randomized trial. BMC Anesthesiol 2014; 14: 89.
34. Robertson CS, Hannay HJ, Yamal JM, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. J Am Med Assoc 2014; 312: 36-47.
35. Shehata N, Burns LA, Nathan H, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012; 52: 91-99.
36. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
37. Walsh TS, Boyd JA, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013; 41: 2354-2363.
38. Webert KE, Cook RJ, Couban S, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008; 48: 81-91.
39. Cholette JM, Swartz MF, Rubenstein J, et al. Outcomes Using a Conservative Versus Liberal Red Blood Cell Transfusion Strategy in Infants Requiring Cardiac Operation. Ann Thorac Surg 2017; 103: 206-214.
40. Blair SD, Janvrin SB, McCollum CN, et al. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 1986; 73: 783-785.
41. Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-424.
42. Carson JL, Carless PA, Hébert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
43. Docherty AB, O’Donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. Br Med J 2016; 352: i1351.